SMMT Stock Price
Summit Therapeutics Inc.
SMMT stock price is $15.39 (-0.87% on the day), giving Summit Therapeutics Inc. a market cap of $12.41B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
SMMT Stock Overview
- Price
- $15.38
- Previous close
- $15.52
- Open
- $15.29
- Market cap
- $12.41B
- 52-week range
- $12.07 - $29.23
- 1-year price target
- $29.06
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NSD
- MarketXLS Rank
- 49
About Summit Therapeutics Inc.
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. Its lead development candidate, ivonescimab, is a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and is also in Phase III clinical trials for the treatment of non-small lung cancer. The company has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab. Summit Therapeutics Inc. was founded in 2003 and is headquartered in Miami, Florida.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SMMT | $15.39 | -0.9% | 1.69M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Summit Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW